Diffuse Diabetic Macular Edema Global Clinical Trials Review, H2, 2017

2017-07-26
Price :
Published : Jul-2017
No. of Pages : 47
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Diffuse Diabetic Macular Edema to Metabolic Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Diffuse Diabetic Macular Edema to Metabolic Disorders Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Diffuse Diabetic Macular Edema Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profile Snapshots 31
Appendix 45
Abbreviations 45
Definitions 45
Research Methodology 46
Secondary Research 46
About GlobalData 47
Contact Us 47
Source 47

List of Tables
Diffuse Diabetic Macular Edema Therapeutics, Global, Clinical Trials by Region, 2017* 7
Diffuse Diabetic Macular Edema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Diffuse Diabetic Macular Edema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 11
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15
Proportion of Diffuse Diabetic Macular Edema to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 17
Diffuse Diabetic Macular Edema Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Diffuse Diabetic Macular Edema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Diffuse Diabetic Macular Edema to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 21
Diffuse Diabetic Macular Edema Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
Diffuse Diabetic Macular Edema Therapeutics, Global, Clinical Trials by Phase, 2017* 23
Diffuse Diabetic Macular Edema Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Diffuse Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List of Figures
Diffuse Diabetic Macular Edema Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Diffuse Diabetic Macular Edema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Diffuse Diabetic Macular Edema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 11
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Proportion of Diffuse Diabetic Macular Edema to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 16
Diffuse Diabetic Macular Edema Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Diffuse Diabetic Macular Edema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Diffuse Diabetic Macular Edema to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 20
Diffuse Diabetic Macular Edema Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
Diffuse Diabetic Macular Edema Therapeutics, Global, Clinical Trials by Phase (%), 2017* 23
Diffuse Diabetic Macular Edema Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Diffuse Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Diffuse Diabetic Macular Edema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
GlobalData Methodology 46
Filed in: Pharmaceutical
Publisher : GlobalData